MORE►
OncoNano
D CEO and Dallas Innovates have announced the 2023 Innovation Awards Finalists
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by Lance Murray | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
by Lance Murray |
Jun 10, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Catalyze Dallas, Flexport, Oceans Healthcare, Costar Technologies, TXOne Networks, North Texas Food Bank, Holt Lunsford Commercial, and others.
MORE►
by Dave Moore |
May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE►
by David Seeley |
Oct 25, 2021
The Cancer Prevention and Research Institute of Texas (CPRIT) will convert previous grant awards to an equity investment. OncoNano uses pH as a biomarker to detect metastatic cancer. The technology "lights up" a tumor in imaging during real-time surgery.
MORE►
OncoNano CEO Martin Driscoll [Photo: OncoNano]
Southlake Biotech OncoNano Medicine Raises $50M in Series B to Accelerate Cancer Tech Toward Commercialization
by Alex Edwards | Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Jeff Bounds |
Jan 22, 2020
Here are notable organizations that veterans of the eye care giant have started or hold executive positions in.
MORE►
by Lance Murray |
Aug 27, 2019
Southlake-based biotech OncoNano received the largest grant in DFW with $15.4 million from the state agency that funds cancer research in Texas.
MORE►
[Image: iStock, jansucko]
Follow the Money: Peloton Therapeutics Files for $150M IPO, Caris Acquires Pharmatech
by Lance Murray | May 2, 2019
You’ll also find news about OncoNano, Mark Cuban, Revint Solutions, Payment Partners, ESO, and eCore Software in this roundup of funding, merger, and acquisition activity involving investors and companies with ties to North Texas.
MORE►
Follow the Money: OncoNano Closes $11.7M Round, Perot Jain Backs 2 Startups, BP Energy Raising $475M
by Lance Murray |
May 17, 2018
From cancer-fighting compounds to startups transforming the retail experience, here's a look at recent funding involving companies and firms with North Texas ties.
MORE►
by Lance Murray |
May 23, 2016
A researcher at UT Dallas has created catalyst materials that could extend battery lives in cellphones and vehicles.
MORE►
